New MRI scan could replace needle test for liver patients
NCT ID NCT05475015
First seen Feb 12, 2026 · Last updated Jun 22, 2026 · Updated 14 times
Summary
This study is testing whether a special MRI scan called 3D-MRE can accurately detect high blood pressure in the liver (portal hypertension) caused by cirrhosis or advanced liver disease. Currently, doctors use an invasive catheter procedure (HVPG) to measure this pressure. The study will enroll 150 adults with chronic liver disease who need an HVPG test, and compare the 3D-MRE results to the standard catheter measurement. If 3D-MRE works well, it could offer a safer, non-invasive way to diagnose and manage these conditions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS, LIVER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shengjing Hospital
RECRUITINGShenyang, Liaoning, 210000, China
Contact Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
3D-MRE (a special MRI scan)
What this could lead to
If successful, this could provide a non-invasive way to diagnose and manage portal hypertension in cirrhosis patients, reducing the need for risky catheter procedures.
What could go wrong
This is an early diagnostic study with 150 participants, so results may not apply to all patients. The accuracy of 3D-MRE might not be high enough to replace current methods.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.